{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:47Z","timestamp":1792793927386,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/tp.0000000000001389","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:05:59Z","timestamp":1470762359000},"page":"1215-1221","source":"Crossref","is-referenced-by-count":66,"title":["A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome"],"prefix":"10.1097","volume":"101","author":[{"given":"Nancy L.","family":"Reinsmoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mirocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Marrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210211","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","article-title":"Humoral theory of transplantation: further evidence","volume":"17","author":"Terasaki","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R2-14-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hfc.2007.02.006","article-title":"Contemporary concepts in noncellular rejection","volume":"3","author":"Kobashigawa","year":"2007","journal-title":"Heart Fail Clin"},{"key":"R3-14-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R4-14-20210211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R5-14-20210211","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R6-14-20210211","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R7-14-20210211","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R8-14-20210211","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R9-14-20210211","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.12-0587","article-title":"Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients","volume":"144","author":"Snyder","year":"2013","journal-title":"Chest"},{"key":"R10-14-20210211","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.healun.2014.02.033","article-title":"Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation","volume":"33","author":"Smith","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R11-14-20210211","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.180.7.4487","article-title":"De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection","volume":"180","author":"Goers","year":"2008","journal-title":"J Immunol"},{"key":"R12-14-20210211","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-\u03b1 1 tubulin and collagen V are associated with chronic rejection after lung transplantation","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"key":"R13-14-20210211","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.healun.2013.06.003","article-title":"Pre-transplant antibodies to K\u03b11 tubulin and collagen-V in lung transplantation: clinical correlations","volume":"32","author":"Tiriveedhi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R14-14-20210211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-14-20210211","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181889748","article-title":"Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation","volume":"86","author":"Dragun","year":"2008","journal-title":"Transplantation"},{"key":"R16-14-20210211","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MOT.0b013e328355f12b","article-title":"Role of non-HLA antibodies in organ transplantation","volume":"17","author":"Dragun","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R17-14-20210211","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum Immunol"},{"key":"R18-14-20210211","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"R19-14-20210211","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"},{"key":"R20-14-20210211","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/TP.0b013e318234b337","article-title":"Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II","volume":"92","author":"Kelsch","year":"2011","journal-title":"Transplantation"},{"key":"R21-14-20210211","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"R22-14-20210211","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"R23-14-20210211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2014","journal-title":"Transpl Immunol"},{"key":"R24-14-20210211","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"key":"R25-14-20210211","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R26-14-20210211","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"R27-14-20210211","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"R28-14-20210211","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/TP.0b013e31821eab8a","article-title":"Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy","volume":"92","author":"Lai","year":"2011","journal-title":"Transplantation"},{"key":"R29-14-20210211","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R30-14-20210211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2014.07.007","article-title":"Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis","volume":"14","author":"Budding","year":"2015","journal-title":"J Cyst Fibros"},{"key":"R31-14-20210211","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-9-49","article-title":"Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease","volume":"9","author":"Lee","year":"2014","journal-title":"Mol Neurodegener"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:25:15Z","timestamp":1620977115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201706000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001389","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}